findmyKOL
Clinical trialNCT02878798CompletedPhase 2Interventional

Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)

SponsorVirginia Commonwealth UniversityEnrollment132Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama Birmingham

    Birmingham, Alabama, United States

  • Barrow Neurological Institute

    Phoenix, Arizona, United States

  • University of California Irvine

    Orange, California, United States

  • University of Miami

    Miami, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Michigan Neurology Clinical Trials Organization

    Ann Arbor, Michigan, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Columbia University Medical Center

    New York, New York, United States

  • University of Rochester Medical Center

    Rochester, New York, United States

  • Wake Forest University Baptist Medical Center

    Winston-Salem, North Carolina, United States

  • Ohio State University

    Columbus, Ohio, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • Eastern Virginia Medical Center

    Norfolk, Virginia, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Feb 2018
Primary completion
28 Sept 2021
Completion
28 Sept 2021
Last update posted
14 Nov 2023
Registered enrollment
132
Registry id
NCT02878798

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.